Scale-up and sustainability of a personalized end-of-life care intervention: a longitudinal mixed-methods study.

Critical care Death Dying Palliative care Quality improvement Scale-up Spiritual care Sustainability

Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
10 Mar 2021
Historique:
received: 21 10 2020
accepted: 03 03 2021
entrez: 11 3 2021
pubmed: 12 3 2021
medline: 15 5 2021
Statut: epublish

Résumé

Scaling-up and sustaining healthcare interventions can be challenging. Our objective was to describe how the 3 Wishes Project (3WP), a personalized end-of-life intervention, was scaled-up and sustained in an intensive care unit (ICU). In a longitudinal mixed-methods study from January 12,013 - December 31, 2018, dying patients and families were invited to participate if the probability of patient death was > 95% or after a decision to withdraw life support. A research team member or bedside clinician learned more about each of the patients and their family, then elicited and implemented at least 3 personalized wishes for patients and/or family members. We used a qualitative descriptive approach to analyze interviews and focus groups conducted with 25 clinicians who cared for the enrolled patients. We used descriptive statistics to summarize patient, wish, and clinician characteristics, and analyzed outcome data in quarters using Statistical Process Control charts. The primary outcome was enrollment of terminally ill patients and respective families; the secondary outcome was the number of wishes per patient; tertiary outcomes included wish features and stakeholder involvement. Both qualitative and quantitative analyses suggested a three-phase approach to the scale-up of this intervention during which 369 dying patients were enrolled, having 2039 terminal wishes implemented. From a research project to clinical program to an approach to practice, we documented a three-fold increase in enrolment with a five-fold increase in total wishes implemented, without a change in cost. Beginning as a study, the protocol provided structure; starting gradually enabled frontline staff to experience and recognize the value of acts of compassion for patients, families, and clinicians. The transition to a clinical program was marked by handover from the research staff to bedside staff, whereby project catalysts mentored project champions to create staff partnerships, and family engagement became more intentional. The final transition involved empowering staff to integrate the program as an approach to care, expanding it within and beyond the organization. The 3WP is an end-of-life intervention which was implemented as a study, scaled-up into a clinical program, and sustained by becoming integrated into practice as an approach to care.

Sections du résumé

BACKGROUND BACKGROUND
Scaling-up and sustaining healthcare interventions can be challenging. Our objective was to describe how the 3 Wishes Project (3WP), a personalized end-of-life intervention, was scaled-up and sustained in an intensive care unit (ICU).
METHODS METHODS
In a longitudinal mixed-methods study from January 12,013 - December 31, 2018, dying patients and families were invited to participate if the probability of patient death was > 95% or after a decision to withdraw life support. A research team member or bedside clinician learned more about each of the patients and their family, then elicited and implemented at least 3 personalized wishes for patients and/or family members. We used a qualitative descriptive approach to analyze interviews and focus groups conducted with 25 clinicians who cared for the enrolled patients. We used descriptive statistics to summarize patient, wish, and clinician characteristics, and analyzed outcome data in quarters using Statistical Process Control charts. The primary outcome was enrollment of terminally ill patients and respective families; the secondary outcome was the number of wishes per patient; tertiary outcomes included wish features and stakeholder involvement.
RESULTS RESULTS
Both qualitative and quantitative analyses suggested a three-phase approach to the scale-up of this intervention during which 369 dying patients were enrolled, having 2039 terminal wishes implemented. From a research project to clinical program to an approach to practice, we documented a three-fold increase in enrolment with a five-fold increase in total wishes implemented, without a change in cost. Beginning as a study, the protocol provided structure; starting gradually enabled frontline staff to experience and recognize the value of acts of compassion for patients, families, and clinicians. The transition to a clinical program was marked by handover from the research staff to bedside staff, whereby project catalysts mentored project champions to create staff partnerships, and family engagement became more intentional. The final transition involved empowering staff to integrate the program as an approach to care, expanding it within and beyond the organization.
CONCLUSIONS CONCLUSIONS
The 3WP is an end-of-life intervention which was implemented as a study, scaled-up into a clinical program, and sustained by becoming integrated into practice as an approach to care.

Identifiants

pubmed: 33691684
doi: 10.1186/s12913-021-06241-6
pii: 10.1186/s12913-021-06241-6
pmc: PMC7944608
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

218

Références

Implement Sci. 2012 Mar 14;7:17
pubmed: 22417162
Implement Sci. 2018 Feb 09;13(1):27
pubmed: 29426341
Res Nurs Health. 2000 Aug;23(4):334-40
pubmed: 10940958
Curr Opin Crit Care. 2019 Oct;25(5):505-510
pubmed: 31313682
BMC Palliat Care. 2020 Jun 30;19(1):93
pubmed: 32605623
Implement Sci. 2017 Sep 2;12(1):110
pubmed: 28865479
Ann Intern Med. 2020 Jan 7;172(1):1-11
pubmed: 31711111
Implement Sci. 2019 Jun 6;14(1):57
pubmed: 31171004
Ann Intern Med. 2015 Aug 18;163(4):271-9
pubmed: 26167721
Health Res Policy Syst. 2019 Sep 13;17(1):84
pubmed: 31519185
Med Educ Online. 2005 Dec;10(1):4387
pubmed: 28253153
CMAJ. 2006 Feb 28;174(5):627-33
pubmed: 16505458
Int J Qual Health Care. 2017 Dec 1;29(8):1014-1019
pubmed: 29177491
PLoS One. 2015 Nov 18;10(11):e0143088
pubmed: 26580406
Crit Care Med. 2017 May;45(5):899-906
pubmed: 28234753

Auteurs

Alyson Takaoka (A)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.

Benjamin Tam (B)

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

Meredith Vanstone (M)

Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.

France J Clarke (FJ)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.

Neala Hoad (N)

Department of Critical Care Medicine, St Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada.

Marilyn Swinton (M)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.

Feli Toledo (F)

Department of Spiritual Care, St Joseph's Healthcare, Hamilton, Ontario, Canada.

Anne Boyle (A)

Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.
Department of Palliative Care, St Joseph's Healthcare, Hamilton, Ontario, Canada.

Anne Woods (A)

Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.
Department of Palliative Care, St Joseph's Healthcare, Hamilton, Ontario, Canada.

Erick H Duan (EH)

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Department of Critical Care Medicine, St Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada.

Diane Heels-Ansdell (D)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.

Lily Waugh (L)

Department of Critical Care Medicine, St Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada.

Mark Soth (M)

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Department of Critical Care Medicine, St Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada.

Jill Rudkowski (J)

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Department of Critical Care Medicine, St Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada.

Waleed Alhazzani (W)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Department of Critical Care Medicine, St Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada.

Dan Perri (D)

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Department of Critical Care Medicine, St Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada.

Tania Ligori (T)

Department of Critical Care Medicine, St Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada.
Department of Anesthesia, McMaster University, Hamilton, Ontario, Canada.

Roman Jaeschke (R)

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Department of Critical Care Medicine, St Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada.

Nicole Zytaruk (N)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.

Deborah J Cook (DJ)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada. debcook@mcmaster.ca.
Department of Medicine, McMaster University, Hamilton, Ontario, Canada. debcook@mcmaster.ca.
Department of Critical Care Medicine, St Joseph's Healthcare Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, L8N 4A6, Canada. debcook@mcmaster.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH